Corneal Pachymetry Market Analysis & Forecast: 2026-2033
The Corneal Pachymetry Market size is anticipated to grow at a CAGR of 4.1% with USD 391.9 Mn in 2026 and is expected to reach USD 519.2 Mn by 2033. The market growth can be attributed to factors such as the growing prevalence of glaucoma and other ophthalmic diseases, increasing need for the early and accurate detection of eye diseases, increasing use of ophthalmic diagnostic equipment, and increasing awareness about the preventive care of eyes. As stated in an American Journal of Ophthalmology study conducted in 2025, the prevalence of open-angle glaucoma in adults 40 years old or older globally in 2024 was 2.8%, or approximately 80.5 million people.
The increasing prevalence of glaucoma and corneal disorders is a key growth driver the corneal pachymetry market. Corneal pachymetry is a key process that aids in the determination of central corneal thickness (CCT), and is vital in the proper determination of intraocular pressure (IOP). Other uses of the procedure include the risk stratification for glaucoma, refractive surgery planning, and keratoconus diagnosis.
According to a 2025 review article published in Clinical Ophthalmology, the review highlights the fact that the measurement of the central corneal thickness (CCT) via corneal pachymetry is an integral part of glaucoma testing and risk factor analysis especially in the cases of adults above the age of 50 years and those suspected of having glaucoma.
In October 2024, Carl Zeiss Meditec AG announced that they will demonstrate their new technological advancements at the American Academy of Ophthalmology (AAO) 2024 meeting, which took place from October 19 to 21, 2024, in Chicago. The company released their new product called ZEISS VisioGen, which is an artificial intelligence-based technology aimed at helping patients better communicate and organize the work of the refractive clinics.
Non-contact methods of testing eyes are becoming increasingly prevalent, which has helped drive the growth of the corneal pachymetry market. Optical pachymetry provides rapid, accurate, and non-contact corneal thickness measurements, reducing infection risk compared to contact-based methods. The incorporation of pachymetry into the process of optical coherence tomography, Scheimpflug imaging, and AI-assisted diagnosis systems has made diagnosis more precise for different conditions including glaucoma, keratoconus, and refractive surgeries.
According to American Academy of Ophthalmology (AAO) Preferred Practice Pattern 2024 concerning glaucoma and suspects, the fundamental tests to be done in order to diagnose the disease in the patients are the Optical Coherence Tomography (OCT) test, which helps evaluate the structure damage in the eye, and central corneal thickness (CCT) measurement through pachymetry.
In September 2024, Oculus introduced the Pentacam Cornea OCT, which is a state-of-the-art diagnostic equipment integrating OCT technology and Scheimpflug imaging in one piece of equipment. The platform uses both OCT and Scheimpflug imaging to analyze corneal thickness, detect ectasia and keratoconus at an early stage, plan surgeries, and improve anterior segment examination. This introduction marked a milestone in non-contact corneal diagnosis.
|
Current Event |
Description and its Impact |
|
March 2025 – Topcon Healthcare Expands Harmony Digital Eye Care Platform Across Europe |
|
|
Expansion of National Eye Screening and Vision Care Programs Worldwide (2024–2025) |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The handheld pachymetry devices are expected to occupy the maximum market share, holding about 61.8% of the total share in 2026. This high share can be attributed to its portable nature, easy usage, fast and reliable results, and increasing use in ophthalmic clinics, ambulatory care centers, and eye-screening campaigns. The handheld pachymeters allow the clinicians to measure the corneal thickness in various healthcare facilities, thus making them very useful for outreach programs.
According to a 2025 scoping review study in BMJ Open, after the evaluation of 216 studies on portable devices for diagnosing glaucoma, it was concluded that such handheld devices showed good correlation with gold standard methods of diagnosis and could be utilized successfully in both clinical and community settings.
In May 2024, Quantel Medical, a part of Lumibird Medical, introduced the release of POCKET III handheld ultrasound pachymeter. According to the manufacturer, this pachymeter is the lightest one among the existing handheld pachymeters, as its weight is 60 grams.
To learn more about this report, Request Free Sample
Based on method type, the optical pachymetry segment leads the market and holds approximately 58.6% of the entire market share by 2026. The dominance of this segment can be attributed to the growing inclination towards non-invasive methods of diagnosis, increased accuracy of measurements, improved patient comfort, and use with OCT and Scheimpflug imaging systems.
According to a 2024 article from The Open Ophthalmology Journal, swept-source optical coherence tomography (SS-OCT) and Scheimpflug camera estimates of central corneal thickness demonstrated an extremely high correlation (Pearson correlation coefficient = 0.989; p<0.0001), thus highlighting the remarkable reliability of modern optical pachymetry techniques.
In February 2025, Optopol Technology published the clinical performance of the REVO FC 130 Anterior Segment Optical Coherence Tomography (OCT) device in the Journal of Clinical Medicine. It was found that the REVO FC 130 offers reliable and repeatable optical pachymetry measurements whose performance is similar to that of the Optovue RTVue XR Avanti OCT device.
By application, glaucoma diagnostics is forecasted to capture the maximum market share of about 49.3% in 2026. Growth in this segment is attributed to rising cases of glaucoma as well as the widespread practice of measuring corneal thickness to understand the intraocular pressure and assess the risk of glaucoma.
According to the 2025 Review of Clinical Ophthalmology, almost 50% of glaucoma sufferers are not diagnosed globally, considering glaucoma is one of the most common causes of permanent blindness. It is noted that pachymetry, which measures the thickness of the central cornea, is crucial when performing the test for glaucoma.
In March 2025, Altris AI launched its Advanced Optic Disc (OD) Analysis module for glaucoma diagnostics. The AI-powered solution analyzes optical coherence tomography (OCT) scans to provide personalized optic disc assessments, evaluate structural glaucomatous damage, and assign a severity score for disease progression.
Hospitals hold the major market share of around 45.7% in 2026 due to their advanced ophthalmic facilities, availability of skilled ophthalmologists, presence of modern equipment for diagnostics, and handling high patient traffic. Hospitals are the prime places for diagnosis of glaucoma, refractive surgery, corneal diseases, and complete eye examination and hence form the largest market segment for corneal pachymetry devices.
According to the American Hospital Association (AHA) Fast Facts (2026), there are 6,100 hospitals, out of which 5,121 hospitals are community hospitals, and these hospitals have more than 33.5 million admissions annually. The huge presence of hospitals and the large number of admissions keep driving the investments in sophisticated ophthalmic diagnostic devices such as corneal pachymeters.
To learn more about this report, Request Free Sample
North America is projected to have a market share of 39.2% in the global Corneal Pachymetry Market during 2026, due to well-developed infrastructure of ophthalmic healthcare in the region, wide adoption of premium technological devices, favorable reimbursement policies and the availability of major players of ophthalmic instruments. Increasing incidence of glaucoma and early diagnosis among others will continue to favor the growth of the segment.
In September 2025, Alcon announced the commercial launch of wavelight plus, the first fully personalized LASIK treatment in the United States, with a Canadian commercial rollout planned for late 2025.
The Asia Pacific region is anticipated to witness the highest growth rate among all regional markets during the 2026–2033 forecast period due to increasing infrastructures related to ophthalmology care, increase in glaucoma surgeries and refractive surgeries, rising awareness about early eye diseases diagnosis, and investment in advanced ophthalmic diagnostic technologies.
According to the World Health Organization (WHO) Western Pacific Regional Office (updated 2025), there are over 90 million people suffering from visual impairment in the Western Pacific Region, out of which 10 million are totally blind.
In April 2025, NIDEK Co., Ltd. participated in the 40th Asia Pacific Academy of Ophthalmology (APAO) Congress, which was held in New Delhi, India, between 3rd to 6th April 2025. NIDEK displayed their new ophthalmic diagnostics devices at the exhibit, taking place from 3rd to 5th April 2025, which included NON-CONTACT TONO/PACHYMETER NT-1p, Optical Coherence Tomography RS-1 Glauvas, Mir.
The U.S. Corneal Pachymetry Market is witnessing steady growth due to rising incidence of glaucoma, an increasing number of elderly people, the extensive use of advanced ophthalmic diagnostics, and significant financial support for thorough eye tests. The U.S. population aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, increasing its share of the total population from 17% to 23%. Corneal pachymetry has become a common diagnostic technique for assessing glaucoma, planning refractive surgery, and treating diseases of the cornea.
According to the National Eye Institute (NEI, updated 2025), there are close to 3 million people suffering from glaucoma in America; however, about half of them do not even know that they have this disease, as the early stages of glaucoma do not have any symptom at all. This rising necessity for early detection is boosting the use of corneal thickness measurements in glaucoma screening.
Japan's corneal pachymetry market is likely to experience substantial growth in the coming years on account of the fast growing elderly population, rising cases of glaucoma, robust ophthalmology infrastructure, and increased use of advanced ophthalmic diagnostics techniques.
According to Japan's Ministry of Internal Affairs and Communications, people aged 65 years and above accounted for approximately 29.3% of Japan's total population in 2025, making Japan one of the world's oldest societies. The growing elderly population is increasing the incidence of glaucoma, corneal diseases, and cataracts, thereby driving demand for routine corneal thickness measurements.
Some of the major key players in Corneal Pachymetry are Micro Medical Devices, Inc. (MMD), Reichert, Inc. (AMETEK Inc.), OCULUS Optikgerate GmbH, Quantel Medical, Optovue Inc., DGH Technology, Inc., Escalon Medical Corp., Carl Zeiss AG, Keeler Ltd., and Konan Medical USA Inc.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 391.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.1% | 2033 Value Projection: | USD 519.2 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Micro Medical Devices, Inc. (MMD), Reichert, Inc. (AMETEK Inc.), OCULUS Optikgerate GmbH, Quantel Medical, Optovue Inc., DGH Technology, Inc., Escalon Medical Corp., Carl Zeiss AG, Keeler Ltd., and Konan Medical USA Inc. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
